AU2696097A - Advanced glycosylation end-product receptor peptides and uses therefor - Google Patents
Advanced glycosylation end-product receptor peptides and uses thereforInfo
- Publication number
- AU2696097A AU2696097A AU26960/97A AU2696097A AU2696097A AU 2696097 A AU2696097 A AU 2696097A AU 26960/97 A AU26960/97 A AU 26960/97A AU 2696097 A AU2696097 A AU 2696097A AU 2696097 A AU2696097 A AU 2696097A
- Authority
- AU
- Australia
- Prior art keywords
- uses therefor
- advanced glycosylation
- glycosylation end
- receptor peptides
- product receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000005622 Receptor for Advanced Glycation End Products Human genes 0.000 title 1
- 108010045108 Receptor for Advanced Glycation End Products Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63314796A | 1996-04-16 | 1996-04-16 | |
| US08633147 | 1996-04-16 | ||
| PCT/EP1997/001832 WO1997039121A1 (en) | 1996-04-16 | 1997-04-11 | Advanced glycosylation end-product receptor peptides and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2696097A true AU2696097A (en) | 1997-11-07 |
Family
ID=24538464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU26960/97A Withdrawn AU2696097A (en) | 1996-04-16 | 1997-04-11 | Advanced glycosylation end-product receptor peptides and uses therefor |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2696097A (en) |
| WO (1) | WO1997039121A1 (en) |
| ZA (1) | ZA973242B (en) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6790443B2 (en) | 1996-11-22 | 2004-09-14 | The Trustees Of Columbia University In The City Of New York | Method for treating symptoms of diabetes |
| US6555651B2 (en) * | 1997-10-09 | 2003-04-29 | The Trustees Of Columbia University In The City Of New York | Ligand binding site of rage and uses thereof |
| US7081241B1 (en) * | 1998-10-06 | 2006-07-25 | The Trustees Of Columbia University In The City Of New York | Extracellular rage binding protein (EN-RAGE) and uses thereof |
| US7101838B2 (en) | 1997-08-05 | 2006-09-05 | The Trustees Of Columbia University In The City Of New York | Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts |
| AU6766800A (en) * | 1999-08-13 | 2001-03-13 | Trustees Of Columbia University In The City Of New York, The | Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| US6908741B1 (en) * | 2000-05-30 | 2005-06-21 | Transtech Pharma, Inc. | Methods to identify compounds that modulate RAGE |
| US6613801B2 (en) | 2000-05-30 | 2003-09-02 | Transtech Pharma, Inc. | Method for the synthesis of compounds of formula I and their uses thereof |
| EP1724589A3 (en) * | 2000-05-30 | 2007-04-25 | TransTech Pharma Inc. | Methods to identify compounds that modulate rage |
| US7919670B1 (en) | 2000-08-14 | 2011-04-05 | The Trustees Of Columbia University In The City Of New York | Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof |
| US6825164B1 (en) * | 2000-08-14 | 2004-11-30 | The Trustees Of Columbia University In The City Of New York | Method to increase cerebral blood flow in amyloid angiopathy |
| AU2002213192A1 (en) | 2000-10-13 | 2002-04-22 | The Trustees Of Columbia University In The City Of New York | A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury |
| JP2005500254A (en) | 2001-03-05 | 2005-01-06 | トランス テック ファーマ,インコーポレイテッド | Carboxamide derivatives as therapeutic factors |
| CA2440037C (en) | 2001-03-05 | 2010-02-16 | Transtech Pharma, Inc. | Benzimidazole derivatives for modulating the rage receptor |
| WO2002070667A2 (en) * | 2001-03-05 | 2002-09-12 | Transtech Pharma, Inc. | High level insect expression of rage proteins |
| US7754217B2 (en) * | 2001-03-16 | 2010-07-13 | Bio3 Research Srl | HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| JP3837494B2 (en) * | 2001-03-19 | 2006-10-25 | 国立大学法人金沢大学 | Soluble RAGE protein |
| CN100525763C (en) | 2002-03-05 | 2009-08-12 | 特兰斯泰克制药公司 | Mono-and bicyclic pyrrole derivatives inhibiting ligand interaction with higher glycation end product receptors |
| WO2005051995A2 (en) * | 2003-11-19 | 2005-06-09 | Curagen Corporation | Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same |
| WO2006012415A2 (en) | 2004-07-20 | 2006-02-02 | Critical Therapeutics, Inc. | Rage protein derivatives |
| MX2007001559A (en) | 2004-08-03 | 2007-04-10 | Transtech Pharma Inc | Rage fusion proteins and methods of use. |
| CA2581505A1 (en) | 2004-09-27 | 2006-04-06 | Centocor, Inc. | Srage mimetibody, compositions, methods and uses |
| US9291621B2 (en) | 2005-01-18 | 2016-03-22 | AbbVie Deutschland GmbH & Co. KG | AGER-peptides and use thereof |
| EP1838339A2 (en) * | 2005-01-18 | 2007-10-03 | Abbott GmbH & Co. KG | Ager-peptides and use thereof |
| US7981424B2 (en) | 2006-05-05 | 2011-07-19 | Transtech Pharma, Inc. | RAGE fusion proteins, formulations, and methods of use thereof |
| PL2158210T3 (en) | 2007-06-14 | 2016-08-31 | Galactica Pharmaceuticals Inc | Rage fusion proteins |
| US9034341B2 (en) | 2009-04-20 | 2015-05-19 | Transtech Pharma, Llc | Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions |
| JP5805646B2 (en) | 2009-09-30 | 2015-11-04 | ブイティーブイ・セラピューティクス・エルエルシー | Substituted imidazole derivatives for the treatment of Alzheimer's disease |
| EP2536283B8 (en) | 2010-02-18 | 2015-11-04 | vTv Therapeutics LLC | Phenyl-heteroaryl derivatives and methods of use thereof |
| JP5999542B2 (en) * | 2010-11-18 | 2016-09-28 | 国立研究開発法人農業・食品産業技術総合研究機構 | Method for detecting molecules having ligand-like activity |
| US9717710B2 (en) | 2012-10-05 | 2017-08-01 | Vtv Therapeutics Llc | Treatment of mild and moderate Alzheimer's disease |
| JP6445861B2 (en) * | 2014-12-18 | 2018-12-26 | 国立大学法人金沢大学 | Sample pretreatment method for oxytocin detection |
| WO2019190822A1 (en) | 2018-03-28 | 2019-10-03 | Vtv Therapeutics Llc | Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine |
| WO2019190823A1 (en) | 2018-03-28 | 2019-10-03 | Vtv Therapeutics Llc | Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine |
| JP7464591B2 (en) | 2018-10-10 | 2024-04-09 | ブイティーブイ・セラピューティクス・エルエルシー | Metabolite of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine |
| JP7262102B2 (en) * | 2019-02-21 | 2023-04-21 | 国立研究開発法人農業・食品産業技術総合研究機構 | Assay system for detecting AGEs |
| JP2021038159A (en) * | 2019-09-02 | 2021-03-11 | 学校法人慶應義塾 | RAGE-derived peptides and their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2506792A (en) * | 1991-08-23 | 1993-03-16 | Rockefeller University, The | Receptors for advanced glycosylation endproducts and uses thereof |
-
1997
- 1997-04-11 AU AU26960/97A patent/AU2696097A/en not_active Withdrawn
- 1997-04-11 WO PCT/EP1997/001832 patent/WO1997039121A1/en active Application Filing
- 1997-04-16 ZA ZA973242A patent/ZA973242B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997039121A1 (en) | 1997-10-23 |
| ZA973242B (en) | 1998-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2696097A (en) | Advanced glycosylation end-product receptor peptides and uses therefor | |
| AU2385597A (en) | Antibodies against the advanced glycosylation end-product receptor and uses thereof | |
| AU6241698A (en) | Tace-like and matrilysin-like polypeptides | |
| AU2237297A (en) | Harness | |
| AUPM434594A0 (en) | Canopy | |
| AU6868398A (en) | Mu-opiate receptor peptides | |
| AU6721696A (en) | Cd44-like protein | |
| AU2972097A (en) | Peptide derivatives | |
| AU3427697A (en) | Securing-piece attaching apparatus | |
| AU1803597A (en) | Peptide derivatives | |
| AU4394396A (en) | Modified peptides | |
| AU3366697A (en) | System for covering | |
| AU2131195A (en) | Prophenins - antibiotic peptides | |
| AU3305197A (en) | Non-activated receptor complex proteins and uses thereof | |
| AU1965497A (en) | Cardiotrophin and uses therefor | |
| AUPM489194A0 (en) | Peptides | |
| AU3986397A (en) | Human glycine transporter | |
| AU8019494A (en) | Human endothelin-bombesin receptor | |
| AU1142397A (en) | Metal-regulated transporters and uses therefor | |
| AU5161296A (en) | Anti-haemorrhagic peptides | |
| AU4151597A (en) | Human dbi/acbp-like protein | |
| AUPM473294A0 (en) | Peptides for diagnostics and therapeutics | |
| AU2498397A (en) | Hair-net sheeting | |
| AU7741098A (en) | Call and connection control | |
| AU2721697A (en) | Glycosylated amylins |